Goodwill of Amneal Pharmaceuticals, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amneal Pharmaceuticals, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Amneal Pharmaceuticals, Inc. Goodwill for the quarter ending 30 Sep 2025 was $595,945,000, a 0.4% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Amneal Pharmaceuticals, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $595,945,000 -$2,379,000 -0.4% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $597,406,000 -$1,127,000 -0.19% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $597,497,000 -$1,052,000 -0.18% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $597,436,000 -$1,193,000 -0.2% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $598,324,000 -$307,000 -0.05% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $598,533,000 -$673,000 -0.11% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $598,549,000 -$607,000 -0.1% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $598,629,000 -$224,000 -0.04% 31 Dec 2023 10-Q 06 Nov 2025 2025 Q3
Q3 2023 $598,631,000 -$873,000 -0.15% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $599,206,000 -$1,768,000 -0.29% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $599,156,000 -$3,737,000 -0.62% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $598,853,000 +$5,836,000 +0.98% 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $599,504,000 +$33,098,000 +5.8% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $600,974,000 +$51,883,000 +9.4% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $602,893,000 +$80,135,000 +15% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $593,017,000 +$70,203,000 +13% 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $566,406,000 +$43,716,000 +8.4% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $549,091,000 +$21,616,000 +4.1% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $522,758,000 +$8,025,000 +1.6% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $522,814,000 +$103,310,000 +25% 31 Dec 2020 10-K 03 Mar 2023 2022 FY
Q3 2020 $522,690,000 +$103,019,000 +25% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $527,475,000 +$107,458,000 +26% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $514,733,000 +$93,093,000 +22% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $419,504,000 -$6,722,000 -1.6% 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $419,671,000 +$9,055,000 +2.2% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $420,017,000 +$33,542,000 +8.7% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $421,640,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $426,226,000 +$399,782,000 +1512% 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $410,616,000 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $386,475,000 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q4 2017 $26,444,000 -$1,997,000 -7% 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q4 2016 $28,441,000 31 Dec 2016 10-K 01 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.